| Accumulation of pathological tau species and memory loss in a conditional model of tauopathy Z Berger, H Roder, A Hanna, A Carlson, V Rangachari, M Yue, Z Wszolek, ... Journal of Neuroscience 27 (14), 3650-3662, 2007 | 567 | 2007 |
| Proteolytic processing of TAR DNA binding protein‐43 by caspases produces C‐terminal fragments with disease defining properties independent of progranulin D Dormann, A Capell, AM Carlson, SS Shankaran, R Rodde, M Neumann, ... Journal of neurochemistry 110 (3), 1082-1094, 2009 | 192 | 2009 |
| Rescue of progranulin deficiency associated with frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase A Capell, S Liebscher, K Fellerer, N Brouwers, M Willem, S Lammich, ... Journal of Neuroscience 31 (5), 1885-1894, 2011 | 150 | 2011 |
| Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancer AM Carlson, MJ Maurer, KM Goergen, KR Kalli, CL Erskine, MD Behrens, ... Cancer epidemiology, biomarkers & prevention 22 (10), 1730-1735, 2013 | 42 | 2013 |
| Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats AC Rising, J Xu, A Carlson, VV Napoli, EM Denovan-Wright, RJ Mandel Experimental neurology 228 (2), 173-182, 2011 | 39 | 2011 |
| Anti-MOG associated disorder–Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD–A single-center experience T Rempe, B Tarhan, E Rodriguez, VT Viswanathan, TV Gyang, A Carlson, ... Multiple Sclerosis and Related Disorders 48, 102718, 2021 | 36 | 2021 |
| A case of GFAP-astroglial autoimmunity presenting with reversible parkinsonism A Tomczak, E Su, M Tugizova, AM Carlson, LB Kipp, H Feng, MH Han Multiple sclerosis and related disorders 39, 101900, 2020 | 25 | 2020 |
| Corticosteroids lead to short-term improvement in cerebral amyloid angiopathy-related inflammation T Rempe, CEV Sollero, E Rodriguez, VT Viswanathan, A Carlson, J Rees, ... Journal of Neuroimmunology 348, 577377, 2020 | 11 | 2020 |
| A prospective, randomized crossover study comparing direct inspection by light microscopy versus projected images for teaching of hematopathology to medical students AM Carlson, ED McPhail, V Rodriguez, G Schroeder, AP Wolanskyj Anatomical Sciences Education 7 (2), 130-134, 2014 | 11 | 2014 |
| Therapy‐related myelodysplasia in a patient with Rothmund–Thomson syndrome AM Carlson, NM Lindor, MR Litzow European journal of haematology 86 (6), 536-540, 2011 | 11 | 2011 |
| Clinical and imaging features of newly recognized Kelch-like protein 11 paraneoplastic syndrome JK Wong, J Yu, A Patterson, A Carlson, A Wagle Shukla Neurology 95 (3), 134-135, 2020 | 7 | 2020 |
| Chronic tibial nonunion in a Rothmund–Thomson syndrome patient AM Carlson, KB Thomas, S Kirmani, NM Lindor American Journal of Medical Genetics Part A 158 (9), 2250-2253, 2012 | 6 | 2012 |
| Anti-JCV antibody index does not change during ocrelizumab-treatment T Rempe, A Carlson, A Miravalle, TV Gyang Multiple Sclerosis Journal–Experimental, Translational and Clinical 6 (3 …, 2020 | 5 | 2020 |
| Five men with arresting and relapsing cerebral adrenoleukodystrophy AM Carlson, IC Huffnagel, A Verrips, MS van der Knaap, M Engelen, ... Journal of neurology 268, 936-940, 2021 | 3 | 2021 |
| Autoimmune hepatitis during treatment of multiple sclerosis with alemtuzumab (P5. 350) A Carlson, N Bozinov, L Kipp, J Dunn, C Lock Neurology 90 (15_supplement), P5. 350, 2018 | 3 | 2018 |
| Prevalence of multiple sclerosis and treatment utilization in a large, highly diverse population AM Carlson, CV Sollero, KV Nair, S Sillau, Q Wu, T Gyang, Z Li, ... Multiple Sclerosis and Related Disorders 61, 103784, 2022 | 2 | 2022 |
| (QOL19) The Mediterranean Diet and Fatigue, Depression, and Emotional Well-being in Multiple Sclerosis: A Study in Patient-Reported Outcomes. J Bolling, CT Rusch, A Kraus, N Tester, N Herndon, A Carlson, ... International Journal of MS Care 22, 2020 | 2 | 2020 |
| A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors IJ Swift, R Rademakers, NC Finch, M Baker, R Ghidoni, L Benussi, ... Alzheimer's research & therapy 16 (1), 66, 2024 | 1 | 2024 |
| Ocrelizumab treatment is not associated with an increase in anti-JCV antibody index (295) T Rempe, A Carlson, A Miravalle, T Gyang Neurology 94 (15_supplement), 295, 2020 | 1 | 2020 |
| Real-world Experience with Ocrelizumab-A Safety Analysis (4199) J Bolling, M Vasquez, CEV Sollero, A Carlson, T Gyang Neurology 94 (15_supplement), 4199, 2020 | 1 | 2020 |
